Cambridge Healthtech Institute’s 6th Annual

Accelerating Target Discovery

Advanced Genomic Technologies, Chemical Biology & Phenotypic Screening, Target Degradation

June 2-4, 2020

 

Finding novel, druggable targets for therapeutic intervention remains a top priority for the pharma/biotech industry. It also remains a formidable challenge and companies continue to invest a lot of time and resources into identifying and validating targets that will yield viable drugs. What are the current challenges? What new tools and strategies are being developed to address those challenges and how well are they working? What’s being done to adequately deconvolute, validate and prioritize the targets once they are identified? What's being done to go after difficult or “undruggable” targets? Cambridge Healthtech Institute’s conference on Emerging Tools for Target Discovery will bring together leading experts to discuss some of these critical questions. This is a unique opportunity for biologists and screening experts to come together to share ideas and best practices, and find a way to populate the drug pipeline with novel, well-characterized drug targets.   

 

Coverage will include, but is not limited to:

 

Advanced Genomic Technologies

  • Using CRISPR, single-cell sequencing for target identification and validation
  • In vivo imaging, in vitro/in situ cell-based and high-content assays for target identification     
  • Exploring genetics-based target discovery
  • Artificial intelligence (AI) and machine learning (ML) tools for target discovery      

 

Chemical Biology & Phenotypic Screening

  • Exploring phenotypic screening using physiologically relevant disease models    
  • Chemoproteomic and transcriptomic profiling for target deconvolution     
  • Developing chemical biology screens for target validation and prioritization
  • Biophysical assays for studying target engagement

 

Target Degradation

  • Using RNAi, CRISPR, and other editing technologies for target validation
  • Using PROTACs and molecular glues for degradation and deconvolution of undruggable targets     
  • Finding the right screening approach to address the biological question being asked
  • Outlining next steps once the target is identified and validated

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is November 22, 2019.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

For more details on the conference, please contact:
Tanuja Koppal, PhD

Senior Conference Director

Cambridge Healthtech Institute

Email: tkoppal@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-K
Rod Eymael
Manager, Business Development
Phone: 781-247-6286
Email: reymael@healthtech.com

 

Companies L-Z
Joseph Vacca, MS
Director, Business Development
Phone: 781-972-5431
Email: jvacca@healthtech.com